Eastern Bank’s Novo Nordisk NVO Stock Holding History

Eastern Bank’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.88M	Sell	122,583 -169,794	-58%	-$7.3M	0.09%	115
2026 Q1	$10.7M	Buy	292,377 +210,000	+255%	+$9.95M	0.18%	102
2025 Q4	$4.19M	Sell	82,377 -8,891	-10%	-$455K	0.07%	114
2025 Q3	$5.06M	Buy	91,268 +1,537	+2%	+$90K	0.09%	104
2025 Q2	$6.19M	Hold	89,731	–	–	0.12%	100
2025 Q1	$6.23M	Sell	89,731 -719	-0.8%	-$59.4K	0.12%	106
2024 Q4	$7.78M	Buy	90,450 +520	+0.6%	+$56.2K	0.14%	114
2024 Q3	$10.7M	Buy	+89,930	New	+$12M	0.19%	111

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Eastern Bank's NVO Position: Q2 2026 in Review

Eastern Bank reduced its Novo Nordisk (NVO) stake by 58% in Q2 2026, selling an estimated $7.3M and leaving 122,583 shares worth $5.88M. The position accounts for 0.09% of the portfolio, ranked #115.

Eastern Bank first reported a position in NVO in Q3 2024 and has held it in 8 quarters since. The position peaked at $10.7M in Q1 2026. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Eastern Bank held 122,583 shares of Novo Nordisk worth $5.88M as of Q2 2026.
Eastern Bank sold 169,794 Novo Nordisk shares in Q2 2026, an estimated $7.3M.
Novo Nordisk made up 0.09% of Eastern Bank's portfolio in Q2 2026, its #115 holding.
Eastern Bank first reported a position in Novo Nordisk in Q3 2024 and has held it in 8 quarters since.
Eastern Bank's Novo Nordisk position peaked at $10.7M in Q1 2026.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.